[Immunosuppressive therapy applied to allogenic lung transplants].
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001706:Biopsy; D004285:Dogs; D004357:Drug Synergism; D006084:Graft Rejection / Q000187:drug effects*; D006854:Hydrocortisone / Q000494:pharmacology / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007167:Immunotherapy; D007279:Injections, Subcutaneous; D016040:Lung Transplantation; D008727:Methotrexate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D010101:Oxygen Consumption; D011817:Rabbits / Q000276:immunology; D014184:Transplantation, Homologous / Q000401:mortality
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D006854:Hydrocortisone; D008727:Methotrexate
Contribution à l'étude des thérapeutiques immuno-suppressives appliguées au transplant pulmonaire allogénique.